Fatemeh Safari | Cancer Therapy | Women Researcher Award

Assist Prof Dr. Fatemeh Safari | Cancer Therapy | Women Researcher Award

Associate Professor at University of Guilan, Iran

Dr. Fatemeh Safari is an accomplished academic and researcher currently serving as an Associate Professor at the University of Guilan, Iran. She holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University, Japan, and has extensive postdoctoral experience at prestigious institutions, including the University of Tokyo and NAIST. Dr. Safari has made significant contributions to the field of microbiology and cancer research, with numerous publications in reputable journals and books. Her work explores the molecular mechanisms underlying cancer progression and treatment, focusing on the therapeutic potential of stem cell secretomes and natural compounds like green tea extracts. Awarded multiple fellowships, including the JSPS Fellowship and Monbukagakusho Scholarship, she has established herself as a leading researcher. Dr. Safari’s expertise is complemented by her commitment to mentoring students and her active involvement in academic collaborations. Her research continues to impact the scientific community, enhancing our understanding of cancer biology and potential therapies.

Profile

Education

Assistant Professor Dr. Fatemeh Safari holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University in Sapporo, Japan, where she completed her degree in 2011. Prior to her doctoral studies, she earned a Master’s degree in Microbiology from the University of Tehran in 2005, further solidifying her foundational knowledge in the biological sciences. Dr. Safari began her academic journey with a Bachelor’s degree in Biology, obtained from the University of Shahid Beheshti in Tehran, Iran, in 1999. Her diverse educational background encompasses a strong focus on molecular and cellular mechanisms, equipping her with the expertise necessary for her research in cancer biology and regenerative medicine. Dr. Safari’s academic achievements reflect her commitment to advancing scientific knowledge and contributing to the fields of microbiology and molecular biology.

Professional Experience

Prof. Dr. Fatemeh Safari has extensive experience in academia and research. Currently, she serves as an Associate Professor at the University of Guilan, Iran, since September 2022, where she has made significant contributions to the field of Molecular and Cellular Biology. Prior to this role, she was an Assistant Professor at the same institution from September 2016 to 2022. Dr. Safari gained valuable research experience as a Postdoctoral Fellow at prestigious institutions in Japan, including NAIST from 2014 to 2015 and The University of Tokyo from 2012 to 2014. Earlier in her career, she worked as a Research Assistant at the University of Tehran from 2005 to 2007. Throughout her career, Dr. Safari has focused on innovative research in microbiology and cancer biology, publishing extensively in reputable journals and contributing to various collaborative research projects. Her academic journey reflects her dedication to advancing scientific knowledge and mentoring future generations of researchers.

Research Interest

Professor Dr. Fatemeh Safari’s research interests lie at the intersection of molecular and cellular biology, with a particular focus on cancer biology, stem cell therapy, and drug development. Her work delves into understanding the molecular mechanisms underlying cancer progression and the potential therapeutic effects of mesenchymal stem cell (MSC) secretomes on various cancer types, including breast and colon cancers. Dr. Safari’s research also explores the modulation of cellular signaling pathways by natural and synthetic compounds, aiming to develop innovative anti-cancer agents. Her investigations into molecular docking, drug synthesis, and the bioactivity of green tea extracts highlight her commitment to finding novel therapeutic approaches. Additionally, she is involved in the development of advanced methodologies, such as spheroid formation and co-culture systems, to study tumor microenvironments. Dr. Safari’s research is highly interdisciplinary, contributing to the fields of oncology, pharmacology, and biotechnology.

Research Skills

Prof. Dr. Fatemeh Safari possesses a diverse array of research skills that significantly contribute to her expertise in molecular and cellular biology. Her extensive experience in microbiology and cancer research equips her with a robust foundation in experimental design and methodology. Proficient in advanced techniques such as molecular docking, cell culture, and the development of in vitro cancer models, she adeptly investigates cellular signaling pathways and the effects of various compounds on cancer cell behavior. Dr. Safari’s analytical skills are demonstrated through her numerous publications, showcasing her ability to synthesize complex data and draw meaningful conclusions. Additionally, her familiarity with both traditional and innovative approaches in microbiology allows her to explore interdisciplinary research opportunities. As a result, she is not only a proficient researcher but also a valuable mentor to emerging scientists, fostering a collaborative and innovative research environment in her laboratory.

Award and Recognition

Prof. Dr. Fatemeh Safari is a distinguished academic in the field of Molecular & Cellular Biology, recognized for her significant contributions to cancer research. She holds a Ph.D. from Hokkaido University and has garnered prestigious fellowships, including the Monbukagakusho Scholarship and the Japan Society for the Promotion of Science Fellowship. As an Associate Professor at the University of Guilan, she has published over 30 research articles in reputable journals and co-authored several book chapters, focusing on the molecular mechanisms of cancer and the therapeutic potential of stem cell secretomes. Her innovative research has earned her recognition within the academic community, and she actively participates in international conferences, sharing her findings and insights. Prof. Dr. Safari’s dedication to advancing scientific knowledge, coupled with her mentorship of emerging researchers, underscores her impactful role in the scientific community, making her a deserving candidate for the Best Researcher Award.

Conclusion

Professor Dr. Fatemeh Safari is a distinguished academic and researcher in the field of Molecular & Cellular Biology, with significant contributions to cancer research and regenerative medicine. Her extensive educational background, including a Ph.D. from Hokkaido University, complements her impressive publication record, featuring numerous articles in reputable journals. As an Associate Professor at the University of Guilan, she has demonstrated leadership in academia while mentoring students and collaborating on innovative research projects. Dr. Safari’s research focuses on the therapeutic potential of human adipose-derived mesenchymal stem cells (hAMSCs) in cancer treatment, highlighting her commitment to advancing scientific knowledge. Her recognition through prestigious fellowships, such as the JSPS Fellowship, underscores her international standing in the scientific community. With her blend of expertise, experience, and a dedication to research excellence, Professor Dr. Fatemeh Safari is a strong candidate for the Best Researcher Award, embodying the qualities of a leading scholar in her field.

Publication Top Notes
  1. Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways
    • Authors: Rasouli, M., Alavi, M., D’Angelo, A., Roudi, R., Safari, F.
    • Year: 2024
    • Journal: International Immunopharmacology
    • Volume/Page: 143, 113265
    • Citations: 0
  2. Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents
    • Authors: Aghahosseini, F., Bayat, M., Sadeghian, Z., Gheidari, D., Safari, F.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume/Issue/Page: 19(9), e0306973
    • Citations: 0
  3. TCAA-promoted novel approach synthesis and in vitro anti-cancer activity evaluation of spiro[indolo[2,1-b]quinazoline-6,4′-pyrano[2,3-c]pyrazole]-5′-carboxamides
    • Authors: Sadeghian, Z., Bayat, M., Eskandari, M., Safari, F.
    • Year: 2024
    • Journal: Results in Chemistry
    • Volume/Page: 9, 101636
    • Citations: 1
  4. The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cells
    • Authors: Safari, F., Bararpour, S., Omidi Chomachaei, F.
    • Year: 2024
    • Journal: Investigational New Drugs
    • Volume/Issue/Page: 42(3), pp. 272–280
    • Citations: 1
  5. Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be Phosphorylated
    • Authors: Rasouli, M., Safari, F., Sobhani, N., Alavi, M., Roudi, R.
    • Year: 2024
    • Journal: DNA and Cell Biology
    • Volume/Issue/Page: 43(2), pp. 74–84
    • Citations: 1
  6. IRTKS Elevation in Patients with Colon Cancer and the Curative Influences of Hamsc Secretome on Polarity and Invasion of HT-29 Colon Cancer Cells
    • Authors: Khodabandeh, A., Safari, F., Ebadi Zavieh, S., Mirzanejad, L.
    • Year: 2024
    • Journal: Regenerative Engineering and Translational Medicine
    • Citations: 0
  7. Harnessing Nanotechnology for Idarubicin Delivery in Cancer Therapy: Current Approaches and Future Perspectives
    • Authors: Safari, F., Jalalian, Y., Abdouss, H., Fathi-Karkan, S., Pandey, S.
    • Year: 2024
    • Journal: BioNanoScience
    • Citations: 2
  8. Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-yl-Pyrimidin-2-yl-Triazole Derivatives as Anti-cancer Agents
    • Authors: Firoozpour, L., Moghimi, S., Fallah Barzegar, M.H., Safari, F., Foroumadi, A.
    • Year: 2024
    • Journal: Polycyclic Aromatic Compounds
    • Volume/Issue/Page: 44(3), pp. 2062–2076
    • Citations: 1
  9. Synthesis and Biological Evaluation of 12-Aryl-11-hydroxy-5,6-dihydropyrrolo[2″,1″:3′,4′]pyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-8(9H)-one Derivatives as Potential Cytotoxic Agents
    • Authors: Barghi Lish, A., Foroumadi, A., Kolvari, E., Safari, F.
    • Year: 2023
    • Journal: ACS Omega
    • Volume/Issue/Page: 8(45), pp. 42212–42224
    • Citations: 1
  10. Evaluation of SgK269 expression in colon cancer patients and the effects of hAMSCs secretome on tumor invasion through SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway in HT-29 colon cancer cells
    • Authors: Safari, F., Ansari Dogaheh, F., Dadashi, H.
    • Year: 2023
    • Journal: 3 Biotech
    • Volume/Issue/Page: 13(11), 346
    • Citations: 1

 

 

Ranal Gurbanov | Cancer Research | Best Researcher Award

Mr. Ranal Gurbanov | Cancer Research | Best Researcher Award

Medical Student at Gazi University School of Medicine, Turkey.

Ranal Gurbanov, an Azerbaijani national born on May 2, 2004, is a promising young individual with a strong academic and humanitarian profile. He earned a bronze medal in the 2019 National Biology Olympiad and participated in the Future Leaders Exchange Program (FLEX) in the U.S., gaining valuable cultural and leadership experiences. Ranal has been recognized for academic excellence by the Baku Department of Education and is actively involved in community service through the “Social and Active Doctors Community (GÜTSAH)” and “KANOPE Blood and Organ Donation Community.” These roles demonstrate his commitment to supporting children with chronic diseases and raising awareness about blood and organ donation. Additionally, Ranal has pursued specialized medical training from prestigious institutions such as the University of Pennsylvania and Acıbadem University. His profile reflects a blend of academic achievement, leadership, and dedication to public health, though he would benefit from further research contributions to strengthen his candidacy for awards.

Profile:

Education

Ranal Gurbanov’s education reflects a strong commitment to academic excellence and personal growth. He began his educational journey with notable achievements at Baku High School No:102, where his exceptional talents earned him an Academic Excellence Award from the Baku Department of Education in 2021. Following this, Ranal participated in the Future Leaders Exchange Program (FLEX), which provided him with an opportunity to study at an American high school and experience a different educational and cultural environment. His commitment to furthering his knowledge is evident in his enrollment in various specialized medical training programs. These include “Vital Signs: Understanding What the Body Is Telling Us” by the University of Pennsylvania, “Clinical Terminology for International and U.S. Students” by the University of Pittsburgh, and several clinical risk management and forensic medicine courses offered by Acıbadem University. This diverse educational background highlights his dedication to both academic and practical learning.

Professional Experience

Ranal Gurbanov has actively engaged in various professional and extracurricular roles that reflect his commitment to both academic excellence and community service. He earned a bronze medal in the 2019 National Biology Olympiad, demonstrating his strong foundational knowledge in biology. His participation in the Future Leaders Exchange Program (FLEX) allowed him to study in the U.S., gaining invaluable cultural and leadership experience. In his volunteer work, Ranal has contributed to the “Social and Active Doctors Community (GÜTSAH),” where he helps improve the lives of children with chronic diseases through moral support and gifts. Additionally, his role in the “KANOPE” Blood and Organ Donation Community showcases his efforts to raise awareness about organ and blood donation, addressing critical healthcare issues in Turkey. His involvement in various medical training programs further highlights his dedication to understanding and improving clinical practices.

Research Interest

Ranal Gurbanov’s research interests are rooted in the intersection of biology, medical ethics, and community health. His early achievements in the National Biology Olympiad reflect a strong foundation in biological sciences, while his academic journey has been enriched by global experiences through the FLEX program, which broadened his understanding of diverse health systems. Ranal’s current focus includes exploring the ethical dimensions of organ donation and transplantation, a field he actively engages in through his role in the “KANOPE Blood and Organ Donation Community.” His interest also extends to clinical risk management and forensic medicine, evidenced by his participation in specialized training programs. Ranal is particularly motivated by addressing public health challenges and improving patient care through innovative approaches. His commitment to community service, coupled with his academic pursuits, underscores a desire to integrate scientific research with practical applications in healthcare.

Research Skills

Ranal Gurbanov has demonstrated a strong foundation in research through his participation in diverse educational and community activities. His involvement in the National Biology Olympiad and subsequent achievements highlight his solid grasp of biological sciences and scientific inquiry. Ranal’s engagement in specialized medical training programs, such as “Vital Signs” and “Clinical Risk Management,” reveals his commitment to understanding complex clinical concepts and research methodologies. Additionally, his role in organizing blood and organ donation awareness campaigns reflects his ability to translate scientific knowledge into public health initiatives. Although his profile is more focused on community service and humanitarian work, these experiences have honed his skills in communication, project management, and ethical considerations in healthcare. To further enhance his research skills, Ranal could benefit from direct involvement in scientific research projects and publications, which would solidify his expertise and contribute to his development as a researcher.

Award and Recognition

Ranal Gurbanov has received notable awards and recognition for his exceptional achievements and contributions. In 2019, he earned a bronze medal at the National Biology Olympiad organized by the Azerbaijan Ministry of Education, highlighting his early excellence in biological sciences. His leadership and adaptability were further recognized when he won the Future Leaders Exchange Program (FLEX) scholarship, allowing him to study in the U.S. and experience diverse cultural values. Additionally, he was honored with the Academic Excellence Award by the Baku Department of Education in 2021 for his outstanding academic performance at Baku High School No:102. Ranal’s commitment to social causes is evident through his active roles in the “Social and Active Doctors Community (GÜTSAH)” and the “KANOPE Blood and Organ Donation Community,” where he has contributed significantly to public health awareness and support for patients with chronic conditions.

Conclusion

Ranal Gurbanov shows tremendous potential and passion, especially in humanitarian and community-driven projects. However, to be a strong candidate for the Best Researcher Award, he needs to enhance his research output and demonstrate more direct contributions to the scientific field through publications or significant research findings. His commitment to learning and social impact is commendable, and with further academic and research development, he could emerge as a future contender.

Publication Top Notes

Ovatodiolide Inhibits Endometrial Cancer Stemness via Reactive Oxygen Species-Mediated DNA Damage and Cell Cycle Arrest

  • Journal: Chemico-Biological Interactions
  • Year: 2024
  • DOI: 10.1016/j.cbi.2024.111244
  • Authors: Chun-Yu Chen, Yu-Zhen Ye, Yu-Hao Huang, Yew-Min Tzeng, Ranal Gurbanov, Wen-Ling Wang, Wen-Wei Chang

 

Mrinal Ghosh | Cancer Biology | Best Researcher Award

Prof. Mrinal Ghosh | Cancer Biology | Best Researcher Award

Chief Scientist at CSIR-Indian Institute of Chemical Biology, India

Dr. Mrinal K. Ghosh is a distinguished Chief Scientist at the CSIR-Indian Institute of Chemical Biology and a Professor at AcSIR, New Delhi. With a Ph.D. in Biochemistry from the University of Calcutta, Dr. Ghosh specializes in cancer biology and inflammatory disorders. His extensive career includes leadership roles at CSIR-IICB and significant contributions to cancer research, particularly in glioma and breast cancer therapies. He has secured substantial funding for projects focusing on novel nanotechnology-based treatments and peptide therapeutics. Dr. Ghosh’s work has earned him prestigious awards such as the Bharat Vikash Award and recognition as a Fellow of the National Academy of Science & Technology. He is an active member of various scientific societies and has a robust publication record in high-impact journals. His research integrates advanced molecular biology techniques and translational medicine to address critical challenges in oncology.

Profile

Education

Dr. Mrinal K. Ghosh completed his education with a strong foundation in biochemistry and molecular biology. He earned his Ph.D. in Biochemistry from the University of Calcutta, India, where he conducted extensive research in the field from 1991 to 1997. Prior to his doctoral studies, Dr. Ghosh obtained his Master of Science degree in Biochemistry, with a focus on Molecular Biology, from the same institution in 1990. His undergraduate studies were in Chemistry, with honors, complemented by Physics and Mathematics, also at the University of Calcutta, culminating in his Bachelor of Science degree in 1988. Dr. Ghosh’s academic journey laid a solid groundwork for his subsequent research and leadership roles in cancer biology and inflammatory disorders, significantly contributing to his reputation as a leading scientist in his field.

Professional Experience

Dr. Mrinal K. Ghosh is a distinguished scientist with a remarkable career in cancer biology and inflammatory disorders. Currently serving as the Chief Scientist and Head of the Cancer Biology & Inflammatory Disorder Division at CSIR-Indian Institute of Chemical Biology (CSIR-IICB), he has been instrumental in advancing research in these fields. Prior to this role, he held positions as Senior Principal Scientist and Principal Scientist at CSIR-IICB, showcasing a trajectory of increasing responsibility. His earlier career included roles as Senior Lecturer at the Department of Biotechnology, HIT, Kolkata, and research positions at the Cleveland Clinic Foundation in the USA. Dr. Ghosh’s extensive experience includes leading significant research projects, managing research teams, and contributing to scientific advancements through his various roles and memberships in professional societies. His career is marked by his dedication to translating scientific discoveries into therapeutic innovations.

Research Interest

Dr. Mrinal K. Ghosh’s research interests focus on advancing cancer biology and inflammatory disorders through innovative biochemical and molecular approaches. His work emphasizes understanding the molecular mechanisms underlying cancer progression, particularly in glioma and breast cancer. Dr. Ghosh investigates the roles of key proteins and signaling pathways, including the p53 and Rb tumor suppressor proteins, and the ubiquitin-proteasome system in regulating cancer cell behavior. His research integrates nanotechnology and peptide therapeutics to develop novel treatment strategies, aiming to enhance the effectiveness of current therapies and overcome resistance. Additionally, Dr. Ghosh explores the implications of cancer biology in the context of stem cell research and neurodegenerative diseases. His comprehensive approach combines preclinical validation, clinical insights, and cutting-edge technology to address critical challenges in cancer treatment and provide new avenues for therapeutic interventions.

Research Skills

Dr. Mrinal K. Ghosh demonstrates exceptional research skills in the field of cancer biology and inflammatory disorders. His expertise spans molecular and cellular mechanisms, particularly in signal transduction related to cancer and stem cells. Dr. Ghosh is proficient in advanced techniques such as nanotechnology-based therapeutic systems, biomolecular target identification, and peptide therapeutic design. His research includes pre-clinical validation of therapies, focusing on glioma and breast cancer, utilizing sophisticated methods like protein modification and nanoparticle-based delivery systems. Dr. Ghosh’s ability to lead large-scale, multi-disciplinary projects is evident from his successful management of significant research grants and collaborations. His extensive publication record in high-impact journals and his role as a reviewer for leading scientific journals highlight his critical analytical skills and contribution to the scientific community. His innovative approach and comprehensive understanding of cancer biology underscore his research prowess.

Award and Recognition

Dr. Mrinal K. Ghosh has garnered significant recognition for his pioneering research in cancer biology and inflammatory disorders. His contributions have been acknowledged through numerous prestigious awards, including the Bharat Vikash Award in 2019, which honors outstanding achievements in scientific research. Dr. Ghosh is also a Fellow of the National Academy of Science & Technology (FNASc) and the Academy of Science & Technology (FAScT), reflecting his esteemed status within the scientific community. His research excellence is further underscored by his role as the Principal Investigator in several high-impact projects, such as the PAN-CSIR Cancer Research initiative and various DST-Nano Mission projects. Additionally, Dr. Ghosh has been honored with the Outstanding Scientist Award on Strategic Management and Business Strategy in 2023. These accolades, coupled with his extensive contributions to scientific literature and research, solidify his standing as a leading figure in his field.

Conclusion

Dr. Mrinal K. Ghosh is highly deserving of the Best Researcher Award due to his outstanding contributions to cancer biology and inflammatory disorders, as evidenced by his awards, extensive research funding, and high-impact publications. His leadership roles and recognition in the scientific community further underscore his excellence. Addressing areas such as enhancing international collaborations and increasing public engagement could further amplify his impact and align with broader scientific and societal goals.

Publications Top Notes

  1. MGMT in TMZ-based Glioma therapy: Multifaceted Insights and Clinical Trial Perspectives
    • Authors: Shaw R, Basu M, Karmakar S, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
  2. Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    • Authors: Ghosh MK*, Roy S
    • Journal: Molecular Biomedicine
    • Year: 2024
    • Volume and Issue: 5(4)
    • Impact Factor: 6.0
    • Citations: 0
  3. E3 Ubiquitin Ligases in Lung Cancer: Emerging Insights and Therapeutic Opportunities
    • Authors: Basu B, Kal S, Karmakar S, Basu M, Ghosh MK*
    • Journal: Life Sciences
    • Year: 2024
    • Volume and Issue: 336, 122333
    • Impact Factor: 6.1
    • Citations: 0
  4. Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    • Authors: Kumar S#, Ansari A#, Basu M#, Ghosh S#, Begam S#, Ghosh MK#*
    • Journal: Advanced Therapeutics
    • Year: 2024
    • Impact Factor: 4.6
    • Citations: 0
    • Status: In press
  5. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    • Authors: Kumar S, Basu M, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
    • Status: In press
  6. Glioma Immunotherapy: Exploring Molecular and Clinical Frontiers
    • Authors: Ghosh MK*, Kumar S, Begam S, Ghosh S, Basu M
    • Journal: Life Sciences
    • Year: 2024
    • Impact Factor: 5.2
    • Citations: 0
    • Status: In press
  7. Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZ
    • Authors: Sarkar S#, Kumar S#, Saha G, Basu M, Ghosh MK*
    • Journal: International Journal of Pharmaceutics
    • Year: 2024
    • Impact Factor: 5.3
    • Citations: 0
    • Status: Under Review (R1)
  8. Unraveling COVID-19 diagnostics: A roadmap for future pandemic
    • Authors: Kumar S, Basu M*, Chakraborty D, Ghosh P, Bajoria S, Ghosh MK*
    • Journal: Nature Cell & Sciences
    • Year: 2024
    • Status: Under Review

2023 Publications:

  1. USP7 – A crucial regulator of Cancer Hallmarks
    • Authors: Saha G, Roy S, Basu M, Ghosh MK*
    • Journal: BBA – Reviews on Cancer
    • Year: 2023
    • Volume and Issue: 1878, 188903
    • Impact Factor: 11.2
    • Citations: 10
  2. Neurological damages in COVID-19 patients: mechanisms and preventive interventions
    • Authors: Sarkar S#, Karmakar S#, Basu M, Ghosh P, Ghosh MK*
    • Journal: MedComm
    • Year: 2023
    • Volume and Issue: 4, e247,1-25
    • Impact Factor: 10.7
    • Citations: 10